
Zimbabwe's medicinal cannabis industry is advancing from cultivation to pharmaceutical manufacturing, with Ivory Medical's new facility in Headlands now producing Active Pharmaceutical Ingredients APIs. This development signifies a move towards local value addition, reducing reliance on raw material exports. Fortune Chagonda, Ivory Medical's quality control manager, stated that the plant adheres to strict international standards and aims to build a structured domestic supply chain. The company sources biomass from licensed local farmers, promoting broader participation while ensuring compliance. Chagonda emphasized that the sector's true value lies in processing and refinement to produce APIs that meet global pharmaceutical requirements, rather than just cultivation. He also noted that infrastructure investment is crucial for competitiveness in this emerging industry. Zimbabwe legalized medicinal cannabis production in 2018, and the emergence of processing facilities is expected to accelerate regulatory reforms and expand licensing frameworks. Local API production is anticipated to decrease the country's pharmaceutical import bill and conserve foreign currency, strengthening the entire value chain.
Free daily or weekly digest of the most important stories from across 18 African countries. No spam, unsubscribe any time.
This summary was AI-generated from a story originally published by NewsDay Zimbabwe.
Must ReadZimbabwe has commissioned a specialized honey testing laboratory to enhance its export competitiveness. This development is part of broader efforts in the country, which include securing duty-free access to China for nearly 9,000 products and ARDA delivering 120,000MT as Zimbabwe prepares for El Ni帽o. Other economic activities include Econet InfraCo expanding its tower rollout and advancing solar projects after its VFEX debut, and Mutapa Gold upgrading its laboratory to reduce exploration costs and boost investor confidence. ART operations have been affected by power outages and raw material shortages, leading to a 6% decline in exports and a 26% decline in paper division volumes in the third quarter to June 2022. New grain levies have been proposed as Zimbabwe addresses climate and food security risks.

Econet InfraCo is expanding its tower rollout and advancing solar projects following its debut on the VFEX. Meanwhile, ART, a manufacturer, reported a decline in export and paper division volumes by 6% and 26% respectively in the third quarter to June 2022, attributing this to power outages and raw material shortages. Zimbabwe has also secured duty-free access to China for nearly 9,000 products and commissioned a specialized honey testing laboratory to boost export competitiveness. Other developments include the government unveiling a five-year tourism strategy, ARDA delivering 120,000MT for El Ni帽o preparedness, and Mutapa Gold upgrading its laboratory to cut exploration costs.
Must ReadZimbabwe has secured duty-free access to the Chinese market for nearly 9,000 product categories under Beijing鈥檚 Pre-Early Harvest Initiative. This arrangement, effective from May 1, 2026, until April 30, 2028, allows qualifying Zimbabwean exports to enter China duty-free under 8,949 tariff lines. Information, Publicity and Broadcasting Services Minister Soda Zhemu stated that this initiative stems from commitments made by China during the 2024 Forum on China-Africa Cooperation. Zimbabwe has completed the administrative requirements, with ZimTrade issuing certificates of origin and the Zimbabwe Revenue Authority verifying compliance. Foreign Affairs and International Trade Minister Amon Murwira noted that the removal of import duties will make Zimbabwean products more competitive in China, but exporters must still meet China鈥檚 stringent regulatory and phytosanitary requirements. The government plans to continue bilateral negotiations during this two-year period to secure a permanent preferential trade agreement after the Pre-Early Harvest Initiative expires.